Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trialResearch in context

Summary: Background: The SECURE trial (NCT02596126) demonstrated the efficacy of the cardiovascular polypill (“CV-Polypill”–acetyl salicylic acid, atorvastatin and ramipril) in reducing the risk of recurrent major cardiovascular events compared with standard care when initiated within six months of...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Thomas Gaziano, José María Castellano, Amy Dymond, Alissa Looby, Stuart Mealing, Ruth Owen, Stuart Pocock, José Ramón González-Juanatey, Alberto Cordero, Antonio Fernández-Ortiz, Aleš Linhart, François Schiele, Wolfram Doehner, Luisa Ojeda Fernández, Valentín Fuster
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2025-08-01
Cyfres:	The Lancet Regional Health. Europe
Pynciau:	Cost-effectiveness analysis Cardiovascular prevention CV-Polypill
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S2666776225001401
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!